Total Payments
$2,750
2024 Payments
$568.69
Companies
16
Transactions
41
Medicare Patients
648
Medicare Billing
$46,788
Payment Breakdown by Category
Food & Beverage$2,709 (98.5%)
Education$40.91 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,709 | 38 | 98.5% |
| Education | $40.91 | 3 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $673.07 | 6 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $350.34 | 3 | $0 (2019) |
| Apellis Pharmaceuticals, Inc. | $331.45 | 3 | $0 (2024) |
| Allergan, Inc. | $261.66 | 4 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $158.59 | 7 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $150.47 | 4 | $0 (2018) |
| Carl Zeiss Meditec USA, Inc. | $147.89 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $122.84 | 3 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $121.56 | 1 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $102.37 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $568.69 | 5 | Bausch & Lomb Americas Inc. ($340.13) |
| 2023 | $582.73 | 7 | Bausch & Lomb Americas Inc. ($332.94) |
| 2022 | $285.45 | 4 | Carl Zeiss Meditec USA, Inc. ($147.89) |
| 2021 | $16.99 | 1 | Allergan, Inc. ($16.99) |
| 2020 | $28.46 | 2 | Novartis Pharmaceuticals Corporation ($28.46) |
| 2019 | $332.24 | 3 | Aerie Pharmaceuticals, Inc. ($234.89) |
| 2018 | $500.72 | 11 | Bausch & Lomb, a division of Bausch Health US, LLC ($158.59) |
| 2017 | $435.02 | 8 | Sun Pharmaceutical Industries Inc. ($139.67) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $121.56 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/19/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 09/10/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $107.00 | General |
| Category: Ophthalmology | ||||||
| 06/17/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $90.14 | General |
| Category: Ophthalmology | ||||||
| 12/07/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 11/30/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $121.05 | General |
| Category: Ophthalmology | ||||||
| 10/26/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $117.26 | General |
| Category: Ophthalmology | ||||||
| 07/27/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $93.29 | General |
| Category: TEPEZZA | ||||||
| 05/04/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: DRY EYE | ||||||
| 04/13/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: TEPEZZA | ||||||
| 03/23/2023 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $90.68 | General |
| 10/13/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $103.40 | General |
| 10/13/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: TEPEZZA | ||||||
| 09/30/2022 | Carl Zeiss Meditec USA, Inc. | ARTEVO 800 (Device) | Food and Beverage | In-kind items and services | $147.89 | General |
| Category: Digital Microscope | ||||||
| 08/04/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Ophthalmology | ||||||
| 12/07/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: DRY EYE | ||||||
| 09/17/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/17/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/18/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $117.65 | General |
| Category: Glaucoma | ||||||
| 06/04/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $97.35 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 05/08/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $117.24 | General |
| Category: Glaucoma | ||||||
| 07/26/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $115.45 | General |
| Category: Ophthalmology | ||||||
| 05/08/2018 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $126.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/04/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX GEL (Drug), PROLENSA | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 167 | 221 | $28,215 | $11,951 |
| 2022 | 7 | 170 | 197 | $38,491 | $10,674 |
| 2021 | 5 | 163 | 203 | $61,756 | $14,327 |
| 2020 | 6 | 148 | 163 | $25,462 | $9,836 |
Total Patients
648
Total Services
784
Medicare Billing
$46,788
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 62 | 70 | $12,250 | $5,706 | 46.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 36 | 57 | $6,840 | $3,447 | 50.4% |
| 92134 | Imaging of retina | Office | 2023 | 27 | 33 | $3,300 | $969.97 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $2,545 | $706.30 | 27.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 16 | 24 | $2,400 | $637.33 | 26.6% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 11 | 22 | $880.00 | $484.66 | 55.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 58 | $10,460 | $3,464 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 40 | $9,662 | $3,284 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,690 | $1,371 | 17.8% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 15 | 15 | $3,010 | $971.96 | 32.3% |
| 92134 | Imaging of retina | Office | 2022 | 32 | 36 | $3,694 | $941.37 | 25.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 12 | 14 | $2,531 | $329.73 | 13.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 11 | 14 | $1,445 | $311.91 | 21.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 65 | $24,771 | $5,672 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 60 | $16,096 | $3,850 | 23.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $15,316 | $3,459 | 22.6% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 28 | 33 | $4,012 | $941.03 | 23.5% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 11 | 14 | $1,562 | $405.44 | 26.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 58 | 58 | $9,860 | $4,568 | 46.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 30 | $3,340 | $1,429 | 42.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 22 | $3,800 | $1,394 | 36.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 11 | 11 | $2,624 | $972.40 | 37.1% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 23 | 28 | $4,200 | $851.63 | 20.3% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 14 | 14 | $1,638 | $621.54 | 37.9% |
About Dr. Laura Pallan, MD
Dr. Laura Pallan, MD is a Ophthalmology healthcare provider based in Coraopolis, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932170230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Pallan, MD has received a total of $2,750 in payments from pharmaceutical and medical device companies, with $568.69 received in 2024. These payments were reported across 41 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,709).
As a Medicare-enrolled provider, Pallan has provided services to 648 Medicare beneficiaries, totaling 784 services with total Medicare billing of $46,788. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Coraopolis, PA
- Active Since 01/27/2006
- Last Updated 02/18/2016
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932170230
Products in Payments
- VYZULTA (Drug) $398.96
- Rhopressa (Drug) $350.34
- MIEBO (Drug) $332.40
- Syfovre (Drug) $228.05
- ARTEVO 800 (Device) $147.89
- Bromsite (Drug) $139.67
- LUMIGAN (Drug) $126.09
- TEPEZZA (Drug) $122.84
- XDEMVY (Drug) $121.56
- KYBELLA (Biological) $118.58
- XIIDRA (Drug) $118.25
- ACTHAR (Biological) $97.35
- BESIVANCE (Drug) $90.23
- LenSx (Device) $74.40
- ARGOS (Device) $22.41
- TYRVAYA (Drug) $17.65
- RESTASIS MULTIDOSE (Drug) $16.99
- PROLENSA (Drug) $12.14
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $10.80
- LOTEMAX GEL (Drug) $9.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.